# Nautilus Biotechnology, Inc.: Form SC 13D/A, filed Nov 14, 2024

- Company: [Nautilus Biotechnology, Inc.](/companies/naut.md) (CIK 1808805)
- Form: SC 13D/A
- Filed: 2024-11-14
- Accepted by EDGAR: Nov 14, 2024, 16:31 ET
- Period: not reported
- Accession: 0001193125-24-258673
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1808805/000119312524258673/d875555dsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1808805/000119312524258673/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1808805/000119312524258673/d875555dsc13da.htm

Filed Nov 14, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-258673. Last ingested by Listed: Nov 3, 2026, 18:40 ET. No prices; not investment advice.